Latest Capital Raises News

Evolution Mining (ASX: EVN) ended March 2026 with a net cash position of $42 million and a $1.37 billion cash balance, driven by strong cash flow from high-margin operations and on-track production.

Aurum Resources has consolidated a 4.2 million ounce gold resource across its Boundiali and Napié projects in Côte d’Ivoire, progressing a central processing hub and expanding drilling programs as it targets development milestones in 2026.

Critical Resources has defined a focused 2026 exploration program at its Mavis Lake lithium project while confirming an orogenic gold system in New Zealand and delivering promising early results from its solid-state lithium-ion battery evaluation.

Westar Resources is pressing forward with its Mageye anomaly exploration in WA's Murchison region while negotiating heritage agreements and managing a $1.15 million cash balance. The company also secured new tenements in the Northern Territory and awaits shareholder approval for a $1.49 million capital raise.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Percheron Therapeutics has closed a $2.2 million entitlement offer to advance its HMBD-002 immuno-oncology candidate towards a phase II trial in 2026, backed by strong shareholder and new investor support.

Truscott Mining’s maiden 2026 drilling at Westminster confirms shear-hosted gold mineralisation and sets the stage for diamond drilling and resource upgrades. Management changes and mining lease applications signal a push towards production.

Cuscal Limited is set to acquire New Zealand payments provider Paymark for A$27 million, funded by a fully underwritten A$30 million institutional placement and a non-underwritten A$3 million share purchase plan. The deal, expected to complete by June 2026, will add scale and geographic diversification while being accretive to earnings in FY27.

Zoono Group has boosted its cash receipts by NZ$333,000 this quarter, driven by initial orders worth NZ$585,000 in its fresh food shelf-life extension sector. Despite operating losses, the company expects to sustain operations through signed contracts and inventory.

Simble Solutions has finalized its acquisition of Next Nano, issuing 600 million shares to the vendor, while also completing a $2.5 million two-tranche placement with attaching options.

Holista Colltech’s shares remain suspended on the ASX following a trading halt linked to ongoing legal issues with ProImmune Company LLC, with no resolution in sight.